Earnings increase 60% over 2024
GUELPH, ON, April 20, 2026 /CNW/ – BIOREM Inc. (TSXV:BRM) (“Biorem” or “the Company”) today announced results for the three- and twelve-month periods ended December 31, 2025. Biorem’s complete fiscal 2025 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
FINANCIAL HIGHLIGHTS:
|
Three months ended |
Twelve months ended |
||||
|
December 31 |
December 31 |
||||
|
2025 |
2024 |
2025 |
2024 |
||
|
Revenue |
16,941 |
9,316 |
42,355 |
37,419 |
|
|
Gross profit |
5,942 |
1,598 |
12,767 |
10,056 |
|
|
Operating Expenses |
2,212 |
|
|||